To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Acquisition from MSD of an API manufacturing business and portfolio of products by Aspen: Conditions precedent met

Release Date: 01/10/2013 09:00
Code(s): APN     PDF:  
Wrap Text
Acquisition from MSD of an API manufacturing business and portfolio of products by Aspen: Conditions precedent met

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen Holdings”)



FURTHER ANNOUNCEMENT REGARDING THE ACQUISITION FROM MSD OF AN API MANUFACTURING
BUSINESS AND PORTFOLIO OF PRODUCTS BY ASPEN - CONDITIONS PRECEDENT MET

Shareholders are referred to the announcement released by Aspen Holdings on 27 June 2013 wherein it
was confirmed that the Aspen Group (“Aspen”) had:

-   signed an agreement with MSD (known as Merck in the United States and Canada) for the acquisition
    of an active pharmaceutical ingredient (“API”) manufacturing business which manufactures for MSD
    and the market generally and which is located in the Netherlands with a satellite facility and sales
    office in the US (“the API Business”); and

-   reached an agreement on an option to acquire a portfolio of 11 branded finished dose form molecules
    (“the Products ”) from MSD, covering a diverse range of therapeutic areas and including products that
    use APIs manufactured by the API Business.

(collectively “the Transactions”)

Aspen Holdings is pleased to announce that the parties have agreed that all the contractual conditions
precedent necessary to implement the acquisition of the API Business have now been met. The API
Business has been transferred to Aspen with effect from today’s date. As confirmed in the announcement
released on 27 June 2013, the expected effective date of the Products acquisition, through the exercise of
the option, is 31 December 2013 and a further announcement will be made once this aspect of the
Transactions has been completed.

Durban
1 October 2013

Underwriters
The Standard Bank of South Africa Limited
Bank of America, N.A.

Mandated Lead Arrangers and Bookrunners
The Standard Bank of South Africa Limited
Banc of America Securities Limited

Sponsor:
Investec Bank Limited

Date: 01/10/2013 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story